v3.26.1
Equity Investments (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 30, 2026
Jul. 31, 2026
Jun. 30, 2026
Jun. 30, 2026
Feb. 05, 2026
Jan. 31, 2026
Jan. 29, 2026
Dec. 31, 2025
Schedule of Equity Method Investments [Line Items]                
Number of shares acquired     480 480        
Bearing interest percentage               12.00%
Warrants exercise price             $ 10.76  
LGG Note [Member] | LifeSci Global Group LLC [Member]                
Schedule of Equity Method Investments [Line Items]                
Note advances maximum amount $ 2,000,000.0              
Bearing interest percentage 7.00%              
Maturity date Apr. 29, 2031              
Face amount     $ 500,000 $ 500,000        
Enquantum Ltd [Member]                
Schedule of Equity Method Investments [Line Items]                
Ownership percentage     34.24% 34.24%        
Investment amount funded       $ 834,000        
Number of shares acquired     85,088 85,088        
Percentage of issued and outstanding shares       34.00%        
Unfunded portion of investment     $ 1,300,000 $ 1,300,000        
Carrying value of investment     714,000 714,000        
Equity method losses     94,000 120,000        
Purchase price exceeded share and underlying net assets     910,000 910,000        
Enquantum Ltd [Member] | Share Purchase Agreement [Member]                
Schedule of Equity Method Investments [Line Items]                
Ownership percentage         51.00%      
Aggregate consideration         $ 2,100,000      
Enquantum Ltd [Member] | Bridge Loan [Member]                
Schedule of Equity Method Investments [Line Items]                
Secured bridge loan           $ 166,000    
LifeSci Global Group LLC [Member]                
Schedule of Equity Method Investments [Line Items]                
Ownership percentage 51.00%              
LifeSci Global Group LLC [Member] | Life Sci Management Group LLC [Member]                
Schedule of Equity Method Investments [Line Items]                
Ownership percentage 49.00%              
Innervate Radiopharmaceuticals LLC [Member] | Subscription Agreement [Member]                
Schedule of Equity Method Investments [Line Items]                
Ownership percentage 0.55%              
Unfunded portion of investment     1,500,000 1,500,000        
Carrying value of investment     $ 500,000 $ 500,000        
Face amount $ 2,000,000.0              
Amount funded for acquisition $ 500,000              
Number of units held 105,263              
Warrants exercise price     $ 4.75 $ 4.75        
Warrants acquired     52,631 52,631        
Innervate Radiopharmaceuticals LLC [Member] | Subscription Agreement [Member] | Subsequent Event [Member]                
Schedule of Equity Method Investments [Line Items]                
Amount funded for acquisition   $ 150,000            
Number of units held   136,842            
Warrants held   68,421